Testing of saliva and serum for HIV in high-risk populations

M. Vall Mayans, J. Casabona, N. Rabella, D. De Miniac, A. Rodés, A. Marco, J. Trabal, C. Trilla

Research output: Contribution to journalArticleResearchpeer-review

13 Citations (Scopus)

Abstract

Paired samples of saliva and serum from 286 highrisk subjects were tested for HIV using two commercial enzyme immunoassays following the same WHO testing strategy supplemented with a Western blot technique. Agreement between HIV testing in both sample types was 98.9 % (95 % confidence interval: 97.7-100). The sensitivity of an EIA (Wellcozyme GACELISA) alone for saliva was 100% (133/133) and the specificity 98.7% (151/153). These results support previous data showing that in some situations saliva might be an effective alternative to serum for HIV testing. © 1995 Springer-Verlag.
Original languageEnglish
Pages (from-to)710-713
JournalEuropean Journal of Clinical Microbiology & Infectious Diseases
Volume14
DOIs
Publication statusPublished - 1 Aug 1995

Fingerprint Dive into the research topics of 'Testing of saliva and serum for HIV in high-risk populations'. Together they form a unique fingerprint.

  • Cite this

    Mayans, M. V., Casabona, J., Rabella, N., De Miniac, D., Rodés, A., Marco, A., Trabal, J., & Trilla, C. (1995). Testing of saliva and serum for HIV in high-risk populations. European Journal of Clinical Microbiology & Infectious Diseases, 14, 710-713. https://doi.org/10.1007/BF01690881